Skip to Content
Merck

117-500

MCDB 105 Medium (500 ml)

Synonym(s):

Primary Cell Culture Media

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.71
UNSPSC Code:
12352207
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

liquid

Quality Level

shelf life

6 mo.

manufacturer/tradename

Cell Applications, Inc

shipped in

wet ice

storage temp.

2-8°C

General description

All-in-one ready-to-use media

Application

MCDB 105 Medium (500 ml) has been used in culturing of human ovarian surface epithelial cells.

Preparation Note

contained in protocol

Analysis Note

Each lot was tested for the ability to support plating, spreading and proliferation

Other Notes

Crystallization caused by low temperatures does not affect product quality or usability and remains safe to use after thawing.


Storage Class

12 - Non Combustible Liquids

wgk

WGK 1



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Christin S Börschel et al.
Biomedicines, 8(8) (2020-08-23)
Downregulated microRNA-142-3p signaling contributes to the pathogenesis of endometriosis, an invasive disease where the lining of the uterus grows at ectopic locations, by yet incompletely understood mechanisms. Using bioinformatics and in vitro assays, this study identifies cytoskeletal regulation and integrin
Anna Stejskalová et al.
Scientific reports, 11(1), 4115-4115 (2021-02-20)
Endometriosis is a painful gynecological condition characterized by ectopic growth of endometrial cells. Little is known about its pathogenesis, which is partially due to a lack of suitable experimental models. Here, we use endometrial stromal (St-T1b), primary endometriotic stromal, epithelial
Xing Xu et al.
British journal of cancer, 125(2), 265-276 (2021-05-14)
Anti-microtubule agents are widely used to treat ovarian cancers, but the efficacy is often compromised by drug resistance. We investigated co-targeting the actin/tropomyosin cytoskeleton and microtubules to increase treatment efficacy in ovarian cancers and potentially overcome resistance. The presence of